Insulin Glargine vs NPH as Basal Insulin on Glycemic Values in Hospitalized Patients: The Inova Diabetes Study
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 08 Aug 2016
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms INOVA Diabetes; InovaDM2
- 03 Aug 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 25 Mar 2015 Planned End Date changed from 1 Aug 2015 to 1 Apr 2016, according to ClinicalTrials.gov record.
- 25 Mar 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Apr 2016, according to ClinicalTrials.gov record.